Loading company…
SONIRE Therapeutics develops focused ultrasound devices for cancer treatment.
SONIRE Therapeutics researches High Intensity Focused Ultrasound devices that use heat to treat cancer tissue. The company was founded in 2020 and is based in Tokyo, Japan. It raised USD 18 million in Series A funding in April 2026 to support clinical trials, regulatory programs, and early commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in